Crossmark

Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis

Crossref DOI link: https://doi.org/10.1007/s13555-023-01043-6

Published Online: 2023-10-18

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Armstrong, April W. https://orcid.org/0000-0003-0064-8707
Park, Sang Hee https://orcid.org/0000-0003-2545-2938
Patel, Vardhaman https://orcid.org/0000-0002-3636-3423
Hogan, Malcolm https://orcid.org/0000-0003-0676-9673
Wang, Wei-Jhih https://orcid.org/0000-0001-7868-5458
Davidson, David https://orcid.org/0009-0003-3100-1540
Chirikov, Viktor https://orcid.org/0000-0002-9480-0580
License Information

Text and Data Mining valid from 2023-10-18

Version of Record valid from 2023-10-18
More Information

Article History

First Online: 18 October 2023